Stanniocalcin-1, a new biomarker of glioma progression, is associated with prognosis of patients

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
Jingyuan SuGuobiao Liang

Abstract

Stanniocalcin-1 (STC1) is a secreted glycoprotein hormone and highly expressed in various types of human malignancies. Although evidence points to the role of STC1 in human cancers, the clinical significance of STC1 expression in glioma has not been established. Here, we investigated the relationship between STC1 expression and clinicopathological significance in glioma. In our study, we selected 60 cases of different grades glioma tissues to detect the expression of STC1. Data showed that the mRNA and protein levels of STC1 in high-grade glioma tissues were significantly higher than that in low-grade tissues. The results of double immunofluorescent staining disclosed STC1 distribution in vascular endothelial cells and the cytoplasm in high-grade glioma, but almost distributed only in vascular endothelial cells in low-grade glioma. By immunohistochemistry, we got the same results and the expression of STC1 has significant difference in high-grade gliomas and low-grade gliomas. Furthermore, the results of Kaplan-Meier analysis indicated that cases with high STC1expression had significantly worse overall survival than those with low level of STC1. These results suggested that STC1 may be a valuable biomarker in diagnosing maligna...Continue Reading

References

May 12, 1998·The American Journal of Physiology·A Wagner, J Boos
Aug 26, 1998·The American Journal of Pathology·K Z ZhangL C Andersson
Jan 3, 2001·Brain Research·A M FranzénL C Andersson
Sep 25, 2003·Endocrine-related Cancer·A C-M ChangR R Reddel
Apr 13, 2005·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Hiroko Ohgaki
Dec 7, 2005·The American Journal of Surgical Pathology·Martin HasselblattWerner Paulus
Jul 10, 2007·Acta Neuropathologica·David N LouisPaul Kleihues
Jan 4, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Markus HuttererAxel Ullrich
Sep 3, 2009·Annals of the New York Academy of Sciences·Giuseppina BasiniFrancesca Grasselli
Dec 8, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Shinya OhkouchiDarwin J Prockop
Oct 3, 2012·Cancer Research·Prakash ChinnaiyanRobert Gillies
Nov 14, 2014·Clinical & Experimental Metastasis·Andy C-M ChangRobin L Anderson

❮ Previous
Next ❯

Citations

May 22, 2016·Molecular Neurobiology·Peiliang GengHoujie Liang
Jan 17, 2020·PLoS Biology·Nathan BasistyBirgit Schilling
May 30, 2020·Journal of Cellular and Molecular Medicine·Fangyu ZhaoYupei Zhao
Aug 23, 2019·Molecular Medicine Reports·Yan Xiong, Qibai Wang
Jan 27, 2019·Laboratory Investigation; a Journal of Technical Methods and Pathology·Zhiwen LiuLiyu He
Mar 30, 2018·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Kristen D BrantleyTimothy L Lash
Apr 27, 2021·Technology in Cancer Research & Treatment·Xiaotao SuChao Qin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.